GSK beats forecasts on back of Covid and shingles treatments
British drugmaker confirms guidance for year in which it will spin-off its consumer goods division
British drugmaker confirms guidance for year in which it will spin-off its consumer goods division
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Government agrees supply deal with GSK for injectable drug sotrovimab
Sotrovimab is effective against all 37 identified mutations in the spike protein, GSK says
Britain’s drug regulator has approved Xevudy treatment
Trial will begin in the first quarter of 2021
Drug to be assessed for ability to stave off infections for up to a year in some people
Crosswords & puzzles to keep you challenged and entertained
Inquests into the nightclub fire that led to the deaths of 48 people
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices